🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out this thread 🔥🔥🔥

Hands down, the best prostate MRI speaker. 🥇

Prostate Imaging Here is the talk for those interested. Jelle Barentsz ProstateUK Profs Andrea Ponsiglione youtu.be/f7kO3uYiLp8?si…

Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0 pubs.rsna.org/doi/10.1148/ra… 🎉 A big congratulations to Masoom Haider Katarzyna Macura Valeria Panebianco Ivo Schoots Caroline Moore Leonardo Kayat Bit..

"New JCAT Online 'Prostate Cancer Risk Prediction Model Using Clinical and MRI–Related Findings: Impact of Combining Lesions’ Locations and Apparent Diffusion Coefficient Values' Mar/Apr 2025 Au: Hirotsugu Nakai et al. Hirotsugu Nakai #radiology #prostatecancer #MRI"

Very important work on Focal Therapy outcomes. Nicely done 🎯

👀 Mucinous adenocarcinoma of the prostate 💦

Encouraging results presented for Aquablation in men with prostate cancer #AUA25. Five-year outcomes are from men on active surveillance who had BPH Aquablation for LUTS. Short term data from 2 prospective cancer Aquablation trials. Complete story here: ir.procept-biorobotics.com/news-events/ev…

Incredible prognostic power of PSMA PET from the updated PROMISE large international registry (PPP2): 3 and 5-yr survival data. Superior to NCCN risk score. Data across initial stage, biochemical recurrence, "non-metastatic" castration-resistant, mSPC, MCRPC !! Just out in

#CLARIFY Trial: Multiday 64Cu-SAR-bisPSMA PET scans refine #ProstateCancerAssessment. Luke Nordquist and Zach Klaassen explore Copper-64 SAR-bisPSMA PET imaging for high-risk #ProstateCancer patients pre-surgery. With Copper-64's extended half-life enabling imaging up to 24 hrs

🔥🔥🔥

🔥

🚨 Must read!

Great cover! 😉

Diagnostic Performance of 68Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer | Journal of Nuclear Medicine 🧲🤝☢️ jnm.snmjournals.org/content/early/…

🔥Restriction Spectrum Imaging as a quantitative biomarker for prostate cancer with reliable positive predictive value | Journal of Urology Amer. Urol. Assn. auajournals.org/doi/10.1097/JU… Congrats Tyler Seibert MD PhD and team.

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

😠🤣

🎯

🔓Open access for a limited time👇